1. Home
  2. AIRI vs BMRA Comparison

AIRI vs BMRA Comparison

Compare AIRI & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Air Industries Group

AIRI

Air Industries Group

N/A

Current Price

$2.65

Market Cap

12.3M

Sector

Industrials

ML Signal

N/A

Logo Biomerica Inc.

BMRA

Biomerica Inc.

N/A

Current Price

$2.24

Market Cap

11.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIRI
BMRA
Founded
1979
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3M
11.5M
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
AIRI
BMRA
Price
$2.65
$2.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.3K
★ 32.3K
Earning Date
11-13-2026
10-13-2026
Dividend Yield
N/A
N/A
EPS Growth
24.39
★ 39.81
EPS
★ N/A
N/A
Revenue
★ $47,921,000.00
$4,453,000.00
Revenue This Year
$4.34
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.30
$1.45
52 Week High
$3.95
$3.21

Technical Indicators

Market Signals
Indicator
AIRI
BMRA
Relative Strength Index (RSI) 45.88 N/A
Support Level $2.55 N/A
Resistance Level $2.76 N/A
Average True Range (ATR) 0.08 0.00
MACD -0.01 0.00
Stochastic Oscillator 26.77 0.00

Price Performance

Historical Comparison
AIRI
BMRA

About AIRI Air Industries Group

Air Industries Group is an aerospace and defense company. Its manufacturers of precision components and assemblies for large aerospace and defense prime contractors. The company products include landing gears, flight controls, engine mounts and components for aircraft jet engines, ground turbines and other complex machines. The ultimate end-user of products is the U.S. Government, international governments, and commercial global airlines.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.

Share on Social Networks: